Last Sunday, February 4th, which is World Cancer Day, the visual and print media in the United States and Europe, especially the Daily Mail newspaper published in London, and the ABC television station in the United States, focused on the new strategy for treating cancers in advanced stages that Professor Philippe developed. Salem received her treatment at the cancer center that bears his name in Houston, Texas.
This treatment is based on combining three treatments: immunotherapy, chemotherapy, and targeted therapy. The treatment is designed to measure the patient and the type of cancer he has. Therefore, treatment varies from one patient to another. No two patients take the same treatment, even if they suffer from the same disease. The treatment protocol is built after determining the biological identity of the disease. This identity is determined after examining the tumor tissue in relation to the map of genes and variants in it. The advantage of this strategy is that this treatment is used for all types of cancer, except for leukemia, and that the drugs used can penetrate the biological barrier between brain tissue and blood vessels, and kill the cancer cells in them. Thus, this treatment saves the need to treat the brain tumor with radiotherapy. In this strategy, we overcome two concepts that were wrong. The first is the belief that all cancer cells in a single patient are the same. The second is that every patient with, for example, lung cancer is like another patient with the same disease. In this study, 60 patients underwent treatment. All of them had exhausted traditional treatments and were left with nothing but certain death. 52% of these patients responded completely to this treatment, and 36% of them responded partially. Thus, the total number of patients who responded reached 88%. Some of those who responded are still alive five years after starting treatment.
The British newspaper Daily Mail asked, “Can we say that Professor Philip Salem is the most important cancer doctor in the world? As he is the only one to this day who uses this strategy.” Because patients from all over the world come to him to undergo this treatment strategy.
Philip Salem says in his humility that knowledge is a cumulative process, rather it is a continuous building process. Your course upon your course. The treatment he developed is a new course in building knowledge. The American Society for Clinical Oncology (ASCO) chose to shed light on Salem’s scientific career in its ASCO POST publication under the title “From a small village in Lebanon to international recognition in cancer medicine.”
In an article he wrote on the occasion of World Cancer Day in Asharq Al-Awsat newspaper, he says, “In my medical career, my eyes were always fixed on the goal. The goal for me was not to obtain the Nobel Prize. Rather, the goal was always, and still is, what is most important and most informative, giving life.”
2024-02-11 22:00:59
#British #Press #Philip #Salem #important #cancer #doctor #world
